Therefore, these therapeutic targets HER-2/neu protein drugs, recombinant humanized anti- HER-2/neu antibody - Herceptin, effective in the treatment of breast cancer has been reported [20]. The gene discussed is ERBB2; the disease is breast carcinoma.